You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

resectable malignant pleural mesothelioma

Showing 1 - 25 of 5,829
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 25, 2022

Mesothelioma Trial in Houston (MEDI4736, Tremelimumab, no other name)

Active, not recruiting
Has Results
  • Mesothelioma
  • Houston, Texas
    Baylor St Lukes
Jan 25, 2022

Surgery for Mesothelioma After Radiation Therapy "SMART" for

Recruiting
  • Mesothelioma
  • Solitary Fibrous Tumor of the Pleura
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Sep 13, 2021

    Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

    Not yet recruiting
    • Pleural Mesothelioma
    • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
    • Rozzano, MI, Italy
    • +5 more
    Nov 30, 2023

    Pleural Mesothelioma Trial in Chicago (Pembrolizumab, Cisplatin and Pemetrexed)

    Recruiting
    • Pleural Mesothelioma
    • Chicago, Illinois
      University of Chicago
    Jun 29, 2021

    Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus

    Not yet recruiting
    • Mesothelioma
    • Durvalumab / tremelimumab
    • Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
    • Durham, North Carolina
    • +1 more
    Jul 5, 2023

    Malignant Pleural Mesothelioma Trial in Toronto (Pre-op RT +/- chemo)

    Recruiting
    • Malignant Pleural Mesothelioma
    • Pre-op RT +/- chemotherapy
    • Toronto, Ontario, Canada
      University Health Network
    Oct 4, 2021

    Malignant Pleural Mesothelioma Trial in Boston (VS-6063)

    Terminated
    • Malignant Pleural Mesothelioma
    • Boston, Massachusetts
      Brigham and Women's Hospital
    May 13, 2021

    Malignant Pleural Mesothelioma Trial in United States (Nivolumab, Pemetrexed, Cisplatin or Carboplatin)

    Recruiting
    • Malignant Pleural Mesothelioma
    • Basking Ridge, New Jersey
    • +6 more
    Jan 26, 2022

    Mesotheliomas Pleural Trial in Rotterdam (Mesopher)

    Recruiting
    • Mesotheliomas Pleural
    • Mesopher
    • Rotterdam, Zuid Holland, Netherlands
      Erasmus MC
    Mar 22, 2022

    Malignant Pleural Mesothelioma Trial in Boston (Pembrolizumab, Defactinib)

    Withdrawn
    • Malignant Pleural Mesothelioma
    • Boston, Massachusetts
    • +1 more
    Nov 16, 2020

    Malignant Pleural Mesothelioma Trial (Proton beam therapy)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Proton beam therapy
    • (no location specified)
    Dec 14, 2022

    Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

    Recruiting
    • Malignant Pleural Mesothelioma, Advanced
    • Oncolytic Adenovirus H101
    • Programmed death receptor-1 inhibitor
    • Tianjin, Tianjin, China
      Tianjin Medical Unversity Second Hospital
    Sep 2, 2023

    Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

    Active, not recruiting
    Has Results
    • Malignant Pleural Mesothelioma
    • Mesothelioma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 5, 2023

    Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Cairo, Egypt
      Ain Shams University Hospital
    Dec 20, 2022

    Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

    Recruiting
    • Mesotheliomas Pleural
    • Amsterdam, Noord-Holland, Netherlands
      Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
    Jan 13, 2023

    Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Dendritic cell vaccination
    • +2 more
    • Edegem, Antwerp, Belgium
    • +2 more
    Feb 28, 2023

    Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)

    Recruiting
    • Malignant Pleural Effusion
    • +3 more
    • Leicester, United Kingdom
    • +5 more
    Oct 28, 2022

    Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

    Completed
    • Pleural Mesothelioma
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)

    Recruiting
    • Malignant Pleural Mesothelioma
    • E-Nose testing
    • Research blood
    • Basking Ridge, New Jersey
    • +6 more
    Sep 8, 2023

    Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)

    Not yet recruiting
    • Pleural Mesothelioma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jul 3, 2023

    Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National

    Not yet recruiting
    • Malignant Pleural Mesotheliomas (Mpm)
    • +4 more
    • Cytoreductive surgery
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)

    Recruiting
    • Malignant Pleural Mesothelioma
    • Chemotherapy Effect
    • hyperthermic intrathoracic chemotherapy
    • Cairo, Egypt
      Ain Shams University hospitals
    Aug 18, 2022

    Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jun 16, 2022

    TTFields in General Routine Clinical Care in Pleural

    Not yet recruiting
    • Pleural Mesothelioma
    • TTFields
    • (no location specified)
    Sep 9, 2022